Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Selatogrel by Idorsia Pharmaceutical for Myocardial Infarction: Likelihood of Approval
Selatogrel is under clinical development by Idorsia Pharmaceutical and currently in Phase III for Myocardial Infarction. According to GlobalData, Phase...